In this Perspective, the authors discuss the various mouse preclinical models that are available for the study of non-alcoholic steatohepatitis (NASH) and NASH-induced hepatocellular carcinoma, and provide advice on reporting practices and how to select the most appropriate model.
- Suchira Gallage
- Jose Efren Barragan Avila
- Mathias Heikenwalder